SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-304817
Filing Date
2014-08-11
Accepted
2014-08-11 16:02:56
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d746806d10q.htm 10-Q 573336
2 EX-31.1 d746806dex311.htm EX-31.1 6786
3 EX-31.2 d746806dex312.htm EX-31.2 6795
4 EX-32.1 d746806dex321.htm EX-32.1 3529
5 EX-32.2 d746806dex322.htm EX-32.2 3538
  Complete submission text file 0001193125-14-304817.txt   4003418

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mack-20140630.xml EX-101.INS 463113
7 XBRL TAXONOMY EXTENSION SCHEMA mack-20140630.xsd EX-101.SCH 46943
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20140630_cal.xml EX-101.CAL 63008
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20140630_def.xml EX-101.DEF 138353
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20140630_lab.xml EX-101.LAB 363817
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20140630_pre.xml EX-101.PRE 251859
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 141030546
SIC: 2834 Pharmaceutical Preparations